MW

Michael Widmann

Investor at Anterra Capital

Boston, Massachusetts

Overview

Work Experience

  • Investor

    2022 - Current

    Boston / Amsterdam Healthtech, Biotech, Nutritiontech, Agtech, Drug Discovery, Foodtech, Animal Health

  • MBA Intern

    2023 - 2023

  • Consultant

    2021 - 2022

    Life Sciences Team Project Lead, managing 3-5 teammembers 20+ due diligences across sectors (healthtech/biotech, consumer goods, technology) Multiple strategy projects including: R&D portfolio prioritizations, supply chain / clinical trial strategy for a covid-19 vaccine manufacturer, M&A growth strategy for major MedTech company, Asset Screen for large Biopharma company Firm Involvement: Green Committee Head (global lead of all sustainability initiatives and carbon offsetting), Pan Mass Challenge Team Captain

  • Senior Associate Consultant

    2020 - 2021

  • Associate Consultant

    2020 - 2020

  • Associate

    2018 - 2020

  • Business Development Fellow

    2018 - 2018

  • Inhouse Consulting Intern

    2017 - 2017

Relevant Websites